(Q34805094)

4 August 2017

1 reference

title

Latanoprost and cholinergic agonists in combination (English)

1 reference

4 August 2017

1 reference

Carol B Toris

1

1 reference

PubMed ID

12204711

4 August 2017

Albert Alm

series ordinal

2

1 reference

PubMed ID

12204711

4 August 2017

Carl B Camras

series ordinal

3

1 reference

4 August 2017

1 August 2002

1 reference

4 August 2017

Survey of Ophthalmology

1 reference

4 August 2017

47 Suppl 1

1 reference

4 August 2017

S141-7

1 reference

Latanoprost administered once daily caused a maintained reduction of intraocular pressure in glaucoma patients treated concomitantly with timolol

4 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2802%2900309-0

7 January 2021

Effects of atropine and pilocarpine on aqueous humour dynamics in cynomolgus monkeys (Macaca irus).

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2802%2900309-0

7 January 2021

Pilocarpine antagonizes prostaglandin F2 alpha-induced ocular hypotension in monkeys. Evidence for enhancement of Uveoscleral outflow by prostaglandin F2 alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2802%2900309-0

7 January 2021

Interaction of PhXA41, a new prostaglandin analogue, with pilocarpine. A study on patients with elevated intraocular pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2802%2900309-0

7 January 2021

Prostaglandin F2 alpha increases uveoscleral outflow in the cynomolgus monkey

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2802%2900309-0

7 January 2021

Latanoprost and physostigmine have mostly additive ocular hypotensive effects in human eyes

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2802%2900309-0

7 January 2021

Prostaglandin action on ciliary smooth muscle extracellular matrix metabolism: implications for uveoscleral outflow.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2802%2900309-0

7 January 2021

Morphological study of the anterior segment of cynomolgus monkey eyes following treatment with prostaglandin F2 alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2802%2900309-0

7 January 2021

Circadian intraocular pressure management with latanoprost: diurnal and nocturnal intraocular pressure reduction and increased uveoscleral outflow.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2802%2900309-0

7 January 2021

Intraocular pressure-reducing effect of PhXA41 in ocular hypertension. Comparison of dose regimens

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2802%2900309-0

7 January 2021

Increased uveoscleral outflow as a possible mechanism of ocular hypotension caused by prostaglandin F2 alpha-1-isopropylester in the cynomolgus monkey.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2802%2900309-0

7 January 2021

Latanoprost for uncontrolled glaucoma in a compassionate case protocol

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2802%2900309-0

7 January 2021

The additive effect of latanoprost to maximum-tolerated medications with low-dose, high-dose, or no pilocarpine therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2802%2900309-0

7 January 2021

Effects of PhXA41, a new prostaglandin F2 alpha analog, on aqueous humor dynamics in human eyes

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2802%2900309-0

7 January 2021

Potential mechanism for the additivity of pilocarpine and latanoprost

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2802%2900309-0

7 January 2021

The effect of prostaglandins on the isolated internal muscles of the mammalian eye, including man

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2802%2900309-0

7 January 2021

Effects of prostaglandins on the aqueous humor outflow pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2802%2900309-0

7 January 2021

10.1016/S0039-6257(02)00309-0

Identifiers

DOI

1 reference

4 August 2017

1 reference

PubMed ID

12204711